Cheaper Sequencing, Higher Costs? | GenomeWeb

The plummeting cost of genome sequencing may likely spur a jump in healthcare spending, Forbes contributor Peter Ubel says, and he thinks that maybe something ought to be done about that.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.